The Latest Regenerative Medicine Articles from Streetwise Reports
Biopharma Co. Posts Positive Data in Ph. 1 Cancer Trials
Nkarta Inc. shares traded over 120% higher after the company reported positive dosing data from two separate Phase 1 clinical trials evaluating the use of natural killer cell therapies to target r/r acute myeloid leukemia and myelodysplastic syndrome and r/r B cell malignancies.FDA Grants RMAT Status for T-Cell Therapy for Six Viruses
Shares of AlloVir Inc. traded 18% higher after the firm reported that the U.S. FDA awarded Regenerative Medicine Advanced Therapy designation to its posoleucel for use in preventing life-threatening infections from six viruses in allogeneic hematopoietic cell transplant patients.Regenerative Medicine Co. Posts 38% Sales Gain in 2021
Organogenesis Holdings Inc. shares traded 23% higher after the company reported FY/21 financial results that included a 46% YoY increase in revenue from its Advanced Wound Care products sales.Showing Results: 1 to 3 of 3